LAVA & Other Techniques¶
Voice feminization surgery (VFS) options outside the "main three" — Wendler's Glottoplasty, Cricothyroid Approximation, and Feminization Laryngoplasty. This page covers LAVA (laser-assisted voice adjustment), vocal fold mass reduction, anterior commissure advancement, bundled protocols (Yeson-style), and the investigational tier (radiofrequency, robotic, absorbable sutures, bioactive scaffolds).
These are alternatives or adjuncts, not replacements. Audience: people who have already read about the main three and are weighing something further out.
Literature is sparse
Almost everything on this page is single-surgeon case-series or conference-abstract level. Randomized comparisons between VFS techniques essentially do not exist, and the niche techniques have even thinner evidence than Wendler's or FemLar. Pitch numbers are reported means from cohorts of <50 patients with <2-year follow-up. Treat ranges as orientation, not as predictions.
Where each technique sits¶
A rough map of mean fundamental-frequency (F0) gain reported in the literature, anchored against the main three for context:
| Technique | Reported mean F0 gain | Evidence quality |
|---|---|---|
| LAVA / laser glottoplasty | ~20–40 Hz | Small case series, drift common |
| Wendler's glottoplasty | ~40–60 Hz | Largest body of evidence among VFS |
| Anterior commissure advancement | Not isolated | Almost always bundled within FemLar |
| Vocal fold mass reduction | Not quantified | Anecdotal / salvage use only |
| FemLar (incl. ACA component) | ~60–80 Hz | Single-center series, short follow-up |
| Yeson-style bundled protocol | ~60–80 Hz | Large but single-center, selection-biased |
LAVA underperforms suture Wendler's on durable pitch elevation. FemLar outperforms everything else on F0 gain and does so with the most invasiveness. The other techniques on this page are positioned as adjuncts, salvage, or experimental.
LAVA — laser de-epithelialization¶
What it is. A CO2 or KTP laser de-epithelializes a strip along the medial edge of the anterior two-thirds of each vocal fold. The denuded edges then heal together and fibrose, shortening the effective vibrating length and raising habitual pitch. Sometimes marketed as "sutureless glottoplasty" or "laser glottoplasty." The mechanism is the same anterior-web concept as Wendler's Glottoplasty, but closure is by healing rather than by suture.
The acronym "LAVA" is not universally adopted — the same procedure shows up in the literature under a half-dozen names depending on surgeon.
Surgeons associated with LAVA-style work.
- James P. Thomas (Portland, OR) — long-time proponent of CO2-laser anterior-web procedures. He calls his variant "feminization laryngoplasty," but it is mechanically a laser glottoplasty, not Mañas-style open FemLar. Same name, different procedure: confirm what you are actually being offered.
- Carlos Mañas (Spain) — primarily known for open FemLar, but has described laser-only and laser-plus-suture hybrids as a smaller part of his practice.
- A handful of ENT surgeons in Korea, Brazil, and the US offer laser-only glottoplasty under various trade names.
Pitch gain vs. Wendler's¶
Reported gains in published case series are roughly 20–40 Hz mean F0 increase, against ~40–60 Hz for suture Wendler's. Drift back toward baseline over 6–24 months is common and expected as the healed web stretches or partially lyses. Final F0 is less predictable than with a suture construct because outcome depends on the patient's fibroblast response, not on a mechanical fixation.
When it's a reasonable choice¶
| Profile | LAVA is a reasonable option |
|---|---|
| Wants a small F0 bump, accepts drift | Yes |
| Using VFS as adjunct to strong voice training | Yes |
| Anatomy or risk factors making suture glottoplasty unattractive | Sometimes |
| Needs a large F0 shift | No — choose FemLar instead |
| Wants the most predictable durable result | No — choose suture Wendler's or FemLar |
Tradeoffs. No external incision, no sutures to fail or extrude, shorter OR time (often 30–60 min vs. 60–120 for Wendler's), and revision is easier because there is no suture construct to take down. Against that: less durable, less predictable, and a small but real risk of producing fold stiffness without much pitch gain — the worst outcome, where range and projection are lost without hitting the target. Anterior-web complications (web too thick, dysphonia, breathiness) also occur.
Vocal fold mass reduction¶
What it is. Endoscopic submucosal resection of thyroarytenoid muscle bulk, or laser ablation of deep lamina propria, to thin the vocal folds. Sometimes called "vocal fold thinning." Conceptually the inverse of Isshiki Type III relaxation thyroplasty (which lowers pitch by shortening the folds). Thinner folds vibrate at higher frequency for the same length and tension, so the expected effect is a perceived rise in pitch and a lighter timbre.
Status. Niche. Not a standard transfeminine offering. It appears as scattered case reports and as part of broader feminization protocols by individual surgeons, not as a standalone published series with quantitative F0 data in transfeminine cohorts.
Salvage / adjunct only
The thyroarytenoid is the main pitch-modulation muscle. Over-resection produces a thin, weak, breathy voice with poor dynamic range — and the damage is permanent. Mass reduction should be considered only when timbre heaviness persists after otherwise successful pitch surgery and timbre-focused voice therapy has been exhausted. It is not a primary feminization technique.
Risks. Permanent stiffness, scarring, breathiness, loss of upper range, reduced loudness.
Anterior commissure advancement (ACA)¶
What it is. Surgical advancement of the anterior commissure of the thyroid cartilage, pulling the front attachment of the folds forward and increasing fold tension. Mechanically related to Cricothyroid Approximation but acts at the anterior end of the folds rather than the cricothyroid joint.
Standalone vs. adjunct. ACA is rarely performed alone for transfeminine indications. It usually appears as a step within Feminization Laryngoplasty, or as an add-on to Wendler's in particular surgeons' personal protocols (some Korean and European surgeons describe an "anterior advancement" component combined with glottoplasty). Standalone published outcomes for trans patients are sparse enough that the independent F0 contribution is essentially unquantified.
Risks. Cartilage fracture, hardware failure if plates or sutures are used, voice quality changes, rare swallowing changes.
Bundled / protocol approaches¶
Some surgeons offer multi-procedure protocols rather than a single technique.
Yeson Voice Center (Seoul). The best-known bundle. Their published protocol historically combines:
- A glottoplasty variant of Wendler's (branded "Voice Feminization Surgery")
- CTA-style tensioning in selected cases
- Tracheal shave as an adjunct cosmetic step (cosmetic only — does not change pitch)
Yeson reports large series (>1000 patients) with mean F0 gains in the 60–80 Hz range and high satisfaction. The evidence base is mostly internal, single-center, and selection-biased; treat the headline numbers as best-case operator-specific rather than generalizable.
Wendler's + CTA in one session. Some North American practices offer a single operative session combining length-shortening (Wendler's) and tension increase (CTA). Larger F0 gains are plausible, but the risks of both procedures stack: higher dysphonia rates, longer recovery, and harder revision if something fails.
Tracheal shave is bundled because patients want the visual change and the trachea is in the same operative field. It is cosmetic, not phonatory.
Investigational and emerging¶
Everything in this section is investigational. Most are pre-clinical, single-surgeon, or small pilot series.
| Technique | Status |
|---|---|
| Bioabsorbable sutures | Trials of PDS / Vicryl in Wendler's to reduce extrusion. Concern that the web may not hold once the suture dissolves. Mixed early results. |
| Radiofrequency glottoplasty | RFG substitutes radiofrequency for CO2 laser at the medial fold edge. Proposed as gentler with more controlled depth. <50 reported cases as of mid-2020s. |
| Robotic-assisted glottoplasty | Transoral robotic surgery (TORS) for suture placement on medial fold edges. Limited to a handful of academic centers; high cost; no clear outcome advantage shown. |
| Bioactive scaffolds / injectables | Hydrogel injection or fold-stiffening biomaterials for pitch elevation. Pre-clinical or first-in-human only. |
Newest tech ≠ best outcome
Outcome data on RFG, robotic glottoplasty, and absorbable sutures is too thin to recommend over standard Wendler's or FemLar unless you are explicitly entering a trial. "Newer" here does not yet mean "better."
Choosing between these¶
A rough orientation frame — not medical advice:
| Goal | Reasonable starting point |
|---|---|
| Small F0 bump, minimally invasive, accept drift | LAVA / laser glottoplasty |
| Maximal F0 gain | FemLar (not on this page) |
| Surgical pitch achieved, voice still reads heavy | Voice therapy first; mass reduction last-line |
| Single trip, bundled cosmetic + phonatory | Yeson-style protocol — accept stacked risks |
| Drawn to robotic / RFG / absorbable sutures | Understand you are choosing experimental over established |
Caveats and evidence quality¶
- The transfeminine VFS literature is dominated by single-surgeon case series with short follow-up. Randomized comparisons between techniques essentially do not exist.
- Pitch outcomes are typically reported as mean F0 change. Patient satisfaction depends on much more — resonance, perceived gender, range, loudness, vocal fatigue. Most series under-report the latter.
- Surgeon volume matters more than acronym choice for procedures of comparable invasiveness. Pick a high-volume operator over a specific name when you can.
- Voice training before and after surgery is the strongest predictor of long-term satisfaction, regardless of which surgical technique is used.
Sources¶
The dedicated literature for the techniques on this page is sparser than for Wendler's, CTA, or FemLar. Many of the references below are conference abstracts, surgeon-site materials, or single-center series — flagged accordingly.
Peer-reviewed series and reviews¶
- Kim HT. Vocal feminization for transgender women: current strategies and patient perspectives. Yeson Voice Center protocol publications, 2017–2022. (Single-center; selection bias likely; the largest reported bundled-protocol cohort.)
- Nuyen B, Kandathil C, Saltychev M, et al. Systematic reviews of pitch-raising surgery in transgender women, Laryngoscope and JAMA Otolaryngology, mid-2020s. (Conclude evidence quality is low and follow-up short across techniques.)
- Casado JC et al. Reviews of voice feminization surgery outcomes (glottoplasty, CTA, FemLar). Small case series, short follow-up.
- Anderson JA. Pitch elevation in trans women: a review of surgical and behavioral approaches. Journal of Voice.
Foundational and adjacent¶
- Isshiki N. Phonosurgery: Theory and Practice. Springer, 1989. (Original Type I–IV thyroplasty descriptions; Type III is the lowering procedure whose inverse is invoked in mass-reduction concepts.)
Lower-confidence references (clinic-marketing or conference-level)¶
Lower confidence
The references below are surgeon-site patient education materials, conference abstracts, or hybrid clinical-marketing publications. They describe the techniques but should not be read as outcome evidence on the level of the peer-reviewed series above.
- Thomas JP. Feminization laryngoplasty — surgeon-site / patient-education materials, voicedoctor.net. Describes a CO2-laser anterior-web technique consistent with the LAVA concept. (Surgeon-site; not peer-reviewed outcomes.)
- Mañas C et al. Publications and conference materials on feminization laryngoplasty and laser-assisted variants (Spain). (Mixed peer-reviewed and conference; laser variants under-reported.)
- Søgaard Nielsen et al. and other Scandinavian/European groups on suture material choice in glottoplasty. (Conference-abstract / small series.)
- Investigational techniques (RFG, robotic glottoplasty, absorbable sutures, bioactive scaffolds): individual conference abstracts (AAO-HNS, ELS, ALA) rather than peer-reviewed series. All preliminary.